eKare Company Profile

Background

Founded in 2014, eKare Inc. is a Software as a Service (SaaS) healthcare company specializing in digital wound care solutions. Originating as a spin-off from the Children's National Medical Center, eKare's mission is to advance the science and delivery of wound care by leveraging mobile and sensor technologies to connect patients, providers, and industry. The company's flagship product, inSight®, is a 3D wound management system that provides comprehensive solutions for the diagnosis, prognosis, and treatment of wounds. eKare's innovative technology is utilized globally across various clinical settings and research institutions, underscoring its significance in the healthcare industry.

Key Strategic Focus

eKare's strategic focus centers on enhancing wound care through advanced imaging, documentation, and analytics. The company specializes in computer vision, workflow management, machine intelligence, and business analytics to provide accurate and convenient 3D wound measurement and documentation at the point of care. eKare's solutions are designed to streamline clinical workflows, improve patient outcomes, and support evidence-based care. The primary markets targeted include inpatient hospitals, skilled nursing facilities, ambulatory clinics, and telemedicine platforms.

Financials and Funding

As of the latest available data, eKare has an estimated annual revenue of approximately $4.1 million, with a revenue per employee of $136,000. The company has experienced a 30% growth in employee count, reaching a total of 30 employees. eKare has raised a total of $137,000 in funding over one round.

Technological Platform and Innovation

eKare's technological platform is distinguished by its proprietary inSight® system, a CE-marked, FDA-registered wound measurement device that utilizes computer vision technology to obtain wound dimensions without the need for a reference marker. The platform's core capabilities include:

Computer Vision: Enables accurate 3D imaging and measurement of wounds.

Workflow Management: Streamlines clinical workflows to enhance efficiency and reduce errors.

Machine Intelligence: Employs artificial intelligence to analyze wound data and support clinical decision-making.

Business Analytics: Provides insights to optimize wound care practices and improve patient outcomes.

The entire eKare platform is compliant with HIPAA, GDPR, and 21 CFR Part 11 standards, ensuring data integrity and security.

Leadership Team

eKare's leadership team comprises experienced professionals dedicated to advancing wound care technology:

Patrick Cheng, Co-Founder & Chief Executive Officer: Brings extensive experience in healthcare technology and business development.

Özgür Güler, Ph.D., Co-Founder & Chief Technology Officer: An imaging scientist with expertise in developing advanced medical imaging solutions.

Kyle Wu, M.D., Co-Founder & Chief Medical Officer: A clinician and biomedical engineer focused on integrating technology into clinical practice.

Daniel York, Chief Commercial Officer: Leads the company's commercial strategy and market expansion efforts.

Additionally, eKare has established a Scientific Advisory Board comprising leading wound care experts, including:

Paul Kim, DPM: Medstar Georgetown University Hospital, Washington, D.C.

Robert S. Kirsner, M.D., Ph.D.: University of Miami Miller School of Medicine, Miami, FL.

John C. Lantis, M.D.: Mount Sinai School of Medicine, New York, NY.

Larry Lavery, DPM: UT Southwestern Medical Center, Dallas, TX.

Competitor Profile

Market Insights and Dynamics:

The digital wound care market is experiencing significant growth, driven by the increasing prevalence of chronic wounds and the demand for advanced wound management solutions. Technological advancements in imaging and data analytics are transforming wound care practices, emphasizing the need for accurate assessment and efficient documentation.

Competitor Analysis:

eKare operates in a competitive landscape with several key players:

MDaaS Global: Operates tech-enabled diagnostic centers for patients, focusing on accessible diagnostic services.

Mercy Radiology: Provides diagnostic imaging services, including radiology and related diagnostics.

MEDcare Urgent Care: Offers patient-focused care for illness and injury, treating patients of all ages with most insurance accepted.

MI&T: A healthcare services company providing various medical services.

These competitors offer a range of diagnostic and imaging services, contributing to the dynamic and evolving wound care market.

Strategic Collaborations and Partnerships

eKare has engaged in significant collaborations to enhance its market position and innovation capacity:

Diabetic Foot Consortium (DFC): Selected by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to join the DFC, aiming to improve outcomes for patients with diabetic foot ulcers.

NHS Digital Health Accelerator: eKare's inSight® system was selected to join this program, designed to expedite the adoption of technology within the NHS by providing support to develop and deploy solutions to pressing healthcare challenges.